Inducible shRNA expression for application in a prostate cancer mouse model
F Czauderna, A Santel, M Hinz, M Fechtner… - Nucleic acids …, 2003 - academic.oup.com
… Application of the inducible shRNA expression system in an orthotopic prostate cancer
mouse model. (A) Prostate tumor volume and lymph node metastasis volume of orthotopically …
mouse model. (A) Prostate tumor volume and lymph node metastasis volume of orthotopically …
… -mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
Y Nasu, CH Bangma, GW Hull, HM Lee, J Hu, J Wang… - Gene therapy, 1999 - nature.com
… Using the RM-9 murine model for prostate we clearly demonstrated significant antitumor
and systemic antimetastatic activities of a single in situ injection of IL-12. It should be …
and systemic antimetastatic activities of a single in situ injection of IL-12. It should be …
[HTML][HTML] Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
JM Tuomela, MP Valta, K Väänänen, PL Härkönen - BMC cancer, 2008 - Springer
… mouse models of cervical cancer [19] and prostate cancer [50]. In addition, both minodronate
and zoledronate affect VEGF interaction with VEGF receptors and signaling in endothelial …
and zoledronate affect VEGF interaction with VEGF receptors and signaling in endothelial …
[HTML][HTML] Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
D Wong, P Kandagatla, W Korz, SR Chinni - BMC urology, 2014 - Springer
… -9908 in an orthotopic prostate cancer model of primary tumor growth and metastases. The
results … and distant metastases in orthotopic mouse model (Figure 3A), however significant …
results … and distant metastases in orthotopic mouse model (Figure 3A), however significant …
Mouse models of prostate cancer
KC Valkenburg, BO Williams - Prostate cancer, 2011 - Wiley Online Library
… as orthotopically into the dorsolateral prostate lobe. Bear in mind that orthotopic implantation
… This model resembled human PCa in that the metastases were found in the lymph node …
… This model resembled human PCa in that the metastases were found in the lymph node …
Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model
Z Hu, J Gupta, Z Zhang, H Gerseny, A Berg… - Human gene …, 2012 - liebertpub.com
… sTβRFc can be developed as potential new therapies for prostate cancer bone metastasis. …
) in a mouse model of prostate cancer bone metastasis. They show that infection of prostate …
) in a mouse model of prostate cancer bone metastasis. They show that infection of prostate …
Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC‐3 in nude mice
Z An, X Wang, J Geller, AR Moossa… - The Prostate, 1998 - Wiley Online Library
… lung and lymph node metastasis of human prostate cancer line PC-3 … metastasis from the
orthotopic site after SOI observed in this study still brings this model of human prostate cancer …
orthotopic site after SOI observed in this study still brings this model of human prostate cancer …
Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial …
… In the present study, using orthotopic models of prostate cancer and prostate cancer
bone metastasis, … transitional cell carcinoma of the bladder in a murine model with the anti-vascular …
bone metastasis, … transitional cell carcinoma of the bladder in a murine model with the anti-vascular …
Combination gene therapy with adenoviral vector-mediated HSV-tk+ GCV and IL-12 in an orthotopic mouse model for prostate cancer
Y Nasu, CH Bangma, GW Hull, G Yang… - … Cancer and Prostatic …, 2001 - nature.com
… inÆltration of immune cells within orthotopic mouse prostate cancer under single AdHSV-tk
áGCV or AdmIL-12 in situ gene therapy and combined treatment conditions. More extensive …
áGCV or AdmIL-12 in situ gene therapy and combined treatment conditions. More extensive …
Model systems of prostate cancer: uses and limitations
NM Navone, CJ Logothetis… - Cancer and metastasis …, 1998 - Springer
… available transgenic mouse models of prostate cancer have … fundamental questions
about the biology of prostate cancer. … ment of a mouse model by using orthotopic (intraprostatic) …
about the biology of prostate cancer. … ment of a mouse model by using orthotopic (intraprostatic) …